Skip to main content

Table 6 The characteristics of clusters in SIPFR

From: Baseline characteristics and survival of patients of idiopathic pulmonary fibrosis: a longitudinal analysis of the Swedish IPF Registry

Variables

Cluster

P-value

1 (n:55)

2 (n:79)

3 (n:39)

A

 Age, years, at enrolment

73 (72–80)

73 (65–77)

68 (66–72)

 < 0.001

 BMI, kg·m2

26.9 (25.0–28.6)

25.8 (23.6–30.8)

27.7 (24.8–30.6)

0.575

 Male (yes, %)

48 (87.3)

33 (47.1)

27 (69.2)

 < 0.001

 Smoking history, (yes, %)

44 (80)

53 (75.7)

26 (66.7)

0.333

 6MWD, m

397 (296–464)

354 (398–516)

415 (377–474)

0.002

 LpSaO2, %

87 (82–90)

90 (87–93)

84 (81–90)

 < 0.001

Comorbidities

 The number of comorbidities

3 (2–3)

1 (0–2)

1 (1–1)

 < 0.001

 CCI

6 (5–7)

4 (3–5)

4 (3–4)

 < 0.001

 Acid reflux, (yes, %)

24 (43.6)

21 (30)

13 (33.3)

0.273

 Heart diseases, (yes, %)

53 (96.4)

29 (41.4)

15 (38.5)

 < 0.001

Severity

 FVC% predicted ≥ 75%, (n, %)

23 (41.8)

56 (80)

2 (5.1)

 < 0.001

 DLCO predicted ≥ 55%, (n, %)

9 (16.4)

46 (65.7)

6 (15.4)

 < 0.001

 TLC predicted ≥ 65%, (n, %)

19 (34)

62 (88.6)

12 (30.8)

 < 0.001

 CPI ≤ 45%, (n, %)

12 (21.8)

62 (88.6)

2 (5.1)

 < 0.001

 GAP stage 1, (n, %)

3 (5.5)

66 (94.3)

6 (15.4)

 < 0.001

  1. Data are presented as median (25th percentile-75th percentile) unless otherwise indicated. IPF idiopathic pulmonary fibrosis, BMI body mass index, CCI Charlson Comorbidity Index, FVC forced vital capacity, DLCO diffusing capacity of carbon monoxide; TLC total lung capacity, GAP gender-age-physiology index for IPF, K-BILD King's brief interstitial lung disease health status questionnaire, 6MWD 6 min walking distance during 6MWT, L-SpO2 Lowest oxygen saturation during 6MWT